Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

YOU WONT BELIEVE: Are wall street analysts bullish on resmed stock - You Need To See This

With a market cap of around $36 billion, ResMed Inc. (RMD) is a global leader in the design, manufacture, and distribution of medical devices and cloud-based software solutions for the treatment of sleep-disordered breathing and other chronic respiratory conditions. The company operates through two primary segments - Sleep and Respiratory Care and Software-as-a-Service, serving patients and healthcare providers worldwide.

Shares of the San Diego, California-based company have outperformed the broader market over the past 52 weeks. RMD has increased 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 10.1%. Moreover, ResMed stock has risen 7.4% on a YTD basis, compared to SPX's marginal decline.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.